RBC Capital Reiterates Outperform Rating on Zimmer Biomet (ZBH)

May 30, 2024 6:24 AM EDT Send to a Friend
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $140.00 price target on Zimmer Biomet (NYSE: ZBH)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login